article thumbnail

Opinion: Reduce drug spending by drastically simplifying monopolies on drugs

STAT

spending on prescription drugs was almost $800 billion. Although low-cost generic drugs filled 91% of all prescriptions, the 9% of prescriptions filled with a branded medicine accounted for 84% of drug spending. In 2024, total U.S.

article thumbnail

Social Media Strategies in Pharma for the Second Half of 2025

Pharma Marketing Network

Pharma teams are now using robust analytics dashboards to track not only impressions and clicks, but also downstream outcomes such as prescription fills, HCP inquiries, and patient enrollment in support programs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Two “Unresolvable” Prescribing/Dispensing Red Flags Unfurled

FDA Law Blog: Biosimilars

We received a response to our post on the prescribing red flags indicating the likelihood of certain prescriptions filled by Walgreens pharmacies were invalid because they lacked a legitimate medical purpose or were not issued in the usual course of professional practice. By Larry K.

article thumbnail

Advances in Digital Advertising Campaigns

Pharma Marketing Network

These tools reveal which digital assets—such as unbranded disease awareness pages or branded landing pages—contribute most to conversion events like doctor visits or prescription fills. Google Analytics 4, multi-touch attribution models, and integrated dashboard tools offer deep insights into user journeys. The results?

article thumbnail

STAT+: Elevance PBM’s president out as customers complain of prescription chaos

STAT

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

article thumbnail

Opinion: Shortages of generic drugs can’t be blamed solely on group purchasing organizations

STAT

More than 90% of prescriptions filled that year were for generics or biosimilars, up from just over 18% the year that Hatch-Waxman was passed. The Hatch-Waxman Act of 1984, which gave rise to the modern generic drug market, was one of the most significant cost-reducing policy innovations of the last 40 years.

article thumbnail

FTC report finds PBM power has “dire consequences”

pharmaphorum

The six largest PBMs in the US manage nearly 95% of all prescriptions filled in the US, a “concentrated market structure” that has allowed them to “profit at the expense of patients and independent pharmacists,” according to the financial regulator.